Prognostic use of cardiac troponin T and troponin I in patients with heart failure.

https://arctichealth.org/en/permalink/ahliterature185756
Source
Can J Cardiol. 2003 Mar 31;19(4):383-6
Publication Type
Article
Date
Mar-31-2003
Author
Jeffrey S Healey
Richard F Davies
Stuart J Smith
Ross A Davies
Daylily S Ooi
Author Affiliation
Division of Cardiology, Ottawa Heart Institute and Department of Medicine, University of Ottawa, Ontario, Canada.
Source
Can J Cardiol. 2003 Mar 31;19(4):383-6
Date
Mar-31-2003
Language
English
Publication Type
Article
Keywords
Aged
Biological Markers
Disease-Free Survival
Female
Heart Failure - blood - diagnosis - mortality - pathology - therapy
Humans
Male
Middle Aged
Ontario - epidemiology
Patient Admission
Predictive value of tests
Prognosis
Prospective Studies
Severity of Illness Index
Troponin I - blood
Troponin T - blood
Abstract
Troponin T (cTnT) and troponin I (cTnI) are present in the sera of some heart failure (HF) patients and have potential importance as prognostic markers.
To prospectively evaluate the prognostic value of cTnT and cTnI in well-characterized HF patients and clarify their relationship to other clinical markers of HF severity.
cTnT and cTnI were measured in 78 HF patients (45 inpatients, 33 outpatients) who were followed up prospectively for 12 months.
Plasma cTnT (> or =0.02 ng/mL) and cTnI (> or =0.3 ng/mL) were detected in 51% and 46% of patients, respectively. These patients were more likely to be inpatients (70% versus 45% for cTnT, 75% versus 43% for cTnI, P
PubMed ID
12704483 View in PubMed
Less detail